Inhibitors of bruton's tyrosine kinase
US9181263B2 · kind B2 · utility
39Cited by
52References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 26, 2015 |
| Grant date | Nov 10, 2015 |
| Priority date | — |
| Expiry date | Jan 26, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are irreversible kinase inhibitor compounds, exemplified by compounds of the following structure:methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of a disease such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.